학술논문

Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial
Document Type
Article
Source
In The Lancet HIV April 2018 5(4):e162-e171
Subject
Primary Research
Articles
Language
ISSN
2352-3018